Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > i'll relay your concerns to analysts with average
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by stockbuphoonon May 26, 2021 4:58pm
60 Views
Post# 33272436

RE:i'll relay your concerns to analysts with average

RE:i'll relay your concerns to analysts with average Remember that there were plenty of analysts estimating $10 for Prometic back in 2017/2018. Analysts estimates mean absolutely nothing. 

realstocky wrote:

price targets of 16,50$ and 18$:) See u posted, i replied.

 

https://www.marketbeat.com/stocks/NASDAQ/LMNL/price-target/

 

LMNL Consensus Rating: Hold Hold Hold Hold
LMNL Consensus Rating Score: 2.20 2.25 2.33 2.00
LMNL Analyst Ratings: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)		 1 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)		 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)		 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
LMNL Consensus Price Target: $18.00 $18.00 $21.50 $21.00
LMNL Price Target Upside: 333.73% upside 283.39% upside 425.67% upside N/A

 

-----------------------------

average price target moved from 11$ to 16,50$;) Buy low, sell high...

LMNL Analyst Research

LMNL Analyst Ratings

Consensus Buy

Based on 4 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

  • BLOOM BURTON&CO
  • H C WAINWRIGHT
  • LEEDE JONES GAB
  • PIPER SANDLER

Analyst

$16.5

Based on analysts offering 12 month price targets for LMNL in the last 3 months. The average price target is $16.5 with a high estimate of $22 and a low estimate of $11. Sign in to your SmartPortfolio to see more analyst recommendations.

 

https://www.nasdaq.com/market-activity/stocks/lmnl/analyst-research


 



<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities